by Renata Dolenec | Nov 28, 2025 | News
A major milestone for ABX-CRO! We are proud to announce that ABX-CRO is now officially registered in India as a Contract Research Organization (CRO) specialized in radiopharmaceutical clinical trials. This marks an important step in expanding our global footprint and...
by Renata Dolenec | Oct 10, 2025 | News
ABX-CRO and ITM (Isotope Technologies Munich) win the prestigious Marie Curie Award of the EANM for outstanding research contributions in nuclear medicine: Dosimetry of the COMPETE study (ITM-11 (n.c.a. 177Lu-DOTATOC) in GEP-NET) The COMPETE (Controlled, Open-label,...
by Lorena Bindszus | May 7, 2025 | News
We are grateful for our team’s dedication and this significant achievement. ABX-CRO is proud to announce the successful completion of an FDA pre-approval inspection for a PET radiodiagnostic with a biological pharmacophore of a global phase III trial conducted by...
by FBorchert | Feb 10, 2025 | News
ABX-CRO wholeheartedly congratulates ITM (Isotope Technologies Munich) to the successful outcome of the COMPETE study (ITM-11 (n.c.a. 177Lu-DOTATOC) in GEP-NET) The success of COMPETE, marks another milestone in ABX-CRO´s unique track record designing and conducting...
by FBorchert | Jan 17, 2025 | News
The scientific and commercial members of the globally unique radiopharmaceutical competence cluster Dresden/Radeberg (Saxony, Germany), comprehensively covering the entire radiopharmaceutical value creation chain from targetry, discovery over R & D, manufacturing,...
by FBorchert | Jan 13, 2025 | News
In 2025 we would like to take the opportunity to welcome our new employee in India: Dr. Rakhee Vatsa! She has started at ABX-CRO India in September 2024 as Technical Head CDMO. Since then she has been awarded the Distinguished Alumnus Award on Dec 21, 2024 by the...
